Lifecore Biomedical Inc
LFCR
Get informed when a big investor buys or sells
+ FollowMarket Cap$154.54M
Close$
$8.08
96.2% upside
Current Fair Value
96.2% upsideUndervalued by 96.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $154.54 Million |
|---|---|
| Enterprise Value | $297.64 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.92 |
| Beta | 1.09 |
| Outstanding Shares | 37,574,538 |
Return
| Return on Equity | -167.50% |
|---|---|
| Return on Assets | -11.75% |
| Return on Invested Capital | 5.25% |
Valuation & Multiples
| P/E Ratio | -3.75 |
|---|---|
| PEG | 2.95 |
| Price to Sales | 1.37 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.4 |
| Enterprise Value to EBIT | 27.28 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0.54 |
| Debt to Equity | 9.96 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.29
Average shareholder expectationRevenue Estimate
$33.13 M
Average shareholder expectationNext Earnings Call
Expected Date
October 2, 2026
EPS Estimate
$-0.29
Average shareholder expectationRevenue Estimate
$25.96 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3355▼ 44.44% |
|---|---|
| Total Calls | 61,700▲ 44.50% |
| Total Puts | 20,700▼ 37.84% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 67.87%▲ 0.86% |
|---|---|
| Total Invested | $134.13M▲ 19.45% |
| Investors Holding | 104▼ 4.00% |
ESG Score
No data
About Lifecore Biomedical Inc
796 employees
CEO: Albert Bolles Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for the foo...